X

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK-0873 in Patients With COPD

Status: Discontinued

Phase of Trial: Phase II/III

Latest Information Update: 06 May 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MK 0873 (Primary)
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use
Sponsors Merck Sharp & Dohme Corp.

Most Recent Events

25 Apr 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
10 Nov 2009 Actual number of patients (604) added as reported by ClinicalTrials.gov.
10 Nov 2009 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com